Literature DB >> 23065486

Effects of combined dietary chromium(III) propionate complex and thiamine supplementation on insulin sensitivity, blood biochemical indices, and mineral levels in high-fructose-fed rats.

Ewelina Król1, Zbigniew Krejpcio, Sławomir Michalak, Rafał W Wójciak, Paweł Bogdański.   

Abstract

Insulin resistance is the first step in glucose intolerance and the development of type 2 diabetes mellitus, thus effective prevention strategies should also include dietary interventions to enhance insulin sensitivity. Nutrients, such as microelement chromium(III) and thiamine, play regulatory roles in carbohydrate metabolism. The objective of this study was to evaluate the insulin-sensitizing potential of the combined supplementary chromium(III) propionate complex (CrProp) and thiamine in insulin resistance animal model (rats fed a high-fructose diet). The experiment was carried out on 40 nine-week-old male Wistar rats divided into five groups (eight animals each). Animals were fed ad libitum: the control diet (AIN-93 M) and high-fructose diets with and without a combination of two levels of CrProp (0.1 and 1 mg Cr/kg body mass/day) and two levels of thiamine (0.5 and 10 mg/kg body mass/day) for 8 weeks. At the end of the experiment rats were sacrificed to collect blood and internal organs for analyses of blood biochemical and hematologic indices as well as tissular microelement levels that were measured using appropriate methods. It was found that both supplementary CrProp and thiamine (given alone) have significant insulin-sensitizing and moderate blood-lipid-lowering properties, while the combined supplementation with these agents does not give synergistic effects in insulin-resistant rats. CrProp given separately increased kidney Cu and Cr levels, while thiamine alone increased hepatic Cu contents and decreased renal Zn and Cu contents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065486      PMCID: PMC3510416          DOI: 10.1007/s12011-012-9515-5

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  60 in total

1.  The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin.

Authors:  B J Clodfelder; J Emamaullee; D D Hepburn; N E Chakov; H S Nettles; J B Vincent
Journal:  J Biol Inorg Chem       Date:  2001-06       Impact factor: 3.358

2.  The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

Authors:  Dee Pei; Chang-Hsun Hsieh; Yi-Jen Hung; Jer-Chuang Li; Chien-Hsing Lee; Shi-Wen Kuo
Journal:  Metabolism       Date:  2006-07       Impact factor: 8.694

3.  Effect of thiamine on the cadmium-chelating capacity of thiol compounds.

Authors:  S K Tandon; S Prasad
Journal:  Hum Exp Toxicol       Date:  2000-09       Impact factor: 2.903

4.  Effect of thiamine administration on metabolic profile, cytokines and inflammatory markers in drug-naïve patients with type 2 diabetes.

Authors:  Manuel González-Ortiz; Esperanza Martínez-Abundis; José A Robles-Cervantes; Viridiana Ramírez-Ramírez; Maria G Ramos-Zavala
Journal:  Eur J Nutr       Date:  2010-07-21       Impact factor: 5.614

5.  Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose.

Authors:  Elena Berrone; Elena Beltramo; Carmela Solimine; Alessandro Ubertalli Ape; Massimo Porta
Journal:  J Biol Chem       Date:  2006-02-01       Impact factor: 5.157

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats.

Authors:  Ayhan Dogukan; Nurhan Sahin; Mehmet Tuzcu; Vijaya Juturu; Cemal Orhan; Muhittin Onderci; James Komorowski; Kazim Sahin
Journal:  Biol Trace Elem Res       Date:  2009-03-07       Impact factor: 3.738

8.  Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men.

Authors:  Pauline Koh-Banerjee; Youfa Wang; Frank B Hu; Donna Spiegelman; Walter C Willett; Eric B Rimm
Journal:  Am J Epidemiol       Date:  2004-06-15       Impact factor: 4.897

9.  Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

Authors:  R Feinstein; H Kanety; M Z Papa; B Lunenfeld; A Karasik
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

10.  Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat.

Authors:  Pitchai Balakumar; Vishal Arvind Chakkarwar; Manjeet Singh
Journal:  Mol Cell Biochem       Date:  2008-10-02       Impact factor: 3.842

View more
  3 in total

1.  Supplementary chromium(III) propionate complex does not protect against insulin resistance in high-fat-fed rats.

Authors:  Ewelina Król; Zbigniew Krejpcio; Katarzyna Iwanik
Journal:  Biol Trace Elem Res       Date:  2014-01-12       Impact factor: 3.738

2.  Re-emergence of thiamine deficiency disease in the Pacific islands (2014-15): A case-control study.

Authors:  Eric J Nilles; Atarota Manaia; Bineta Ruaia; Clare Huppatz; Catherine Ward; Peter George; Christiaan Sies; Alessio Cangiano; James Sejvar; André Reiffer; Teatoa Tira
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

3.  Effects of Bitter Melon and a Chromium Propionate Complex on Symptoms of Insulin Resistance and Type 2 Diabetes in Rat Models.

Authors:  Pandora E White; Ewelina Król; Artur Szwengiel; Małgorzata Tubacka; Dawid Szczepankiewicz; Halina Staniek; John B Vincent; Zbigniew Krejpcio
Journal:  Biol Trace Elem Res       Date:  2020-06-02       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.